FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308366609> ?p ?o ?g. }

• W4308366609 endingPage "e2240403" @default.
• W4308366609 startingPage "e2240403" @default.
• W4308366609 abstract "Maximizing benefits of lung cancer screening requires timely follow-up after a positive screening test. The American College of Radiology (ACR) Lung CT Screening Reporting and Data System (Lung-RADS) recommends testing and follow-up timing based on the screening result.To determine rates of and factors associated with recommended follow-up after a positive lung cancer screening examination by Lung-RADS category.This prospective cohort study of lung cancer screening examinations performed from January 1, 2015, through July 31, 2020, with follow-up through July 31, 2021, was conducted at 5 academic and community lung cancer screening sites in North Carolina. Participants included 685 adults with a positive screening examination, Lung-RADS categories 3, 4A, 4B, or 4X. Statistical analysis was performed from December 2020 to March 2022.Individual age, race, sex, smoking exposure, year of lung cancer screening examination, chronic obstructive pulmonary disease, body mass index, referring clinician specialty, rural or urban residence.Adherence, defined as receipt of recommended follow-up test or procedure after the positive screen per ACR Lung-RADS timeframes: 6 months for Lung-RADS 3 and 3 months for Lung-RADS 4A. For Lung-RADS 4B or 4X, adherence was defined as follow-up care within 4 weeks, as ACR Lung-RADS does not specify a timeframe.Among the 685 individuals included in this study who underwent lung cancer screening with low-dose computed tomography, 416 (60.7%) were aged at least 65 years, 123 (18.0%) were Black, 562 (82.0%) were White, and 352 (51.4%) were male. Overall adherence to recommended follow-up was 42.6% (292 of 685) and varied by Lung-RADS category: Lung-RADS 3 = 30.0% (109 of 363), Lung-RADS 4A = 49.5% (96 of 194), Lung-RADS 4B or 4X = 68.0% (87 of 128). Extending the follow-up time increased adherence: Lung-RADS 3 = 68.6% (249 of 363) within 9 months, Lung-RADS 4A = 77.3% (150 of 194) within 5 months, and Lung-RADS 4B or 4X = 80.5% (103 of 128) within 62 days. For Lung-RADS 3, recommended follow-up was less likely among those currently smoking vs those who quit (adjusted odds ratio [aOR], 0.48; 95% CI, 0.29-0.78). In Lung-RADS 4A, recommended follow-up was less likely in Black individuals vs White individuals (aOR, 0.35; 95% CI, 0.15-0.86). For Lung-RADS 4B or 4X, recommended follow-up was more likely in female individuals vs male individuals (aOR, 2.82; 95% CI, 1.09-7.28) and less likely in those currently smoking vs those who quit (aOR, 0.31; 95% CI, 0.12-0.80).In this cohort study, adherence to recommended follow-up after a positive screening examination was low but improved among nodules with a higher suspicion of cancer and after extending the follow-up timeline. However, the association of extending the follow-up time of screen-detected nodules with outcomes at the population level, outside of a clinical trial, is unknown. These findings suggest that studies to understand why recommended follow-up is lower in Black individuals, male individuals, and individuals currently smoking are needed to develop strategies to improve adherence." @default.
• W4308366609 created "2022-11-11" @default.
• W4308366609 creator A5004646355 @default.
• W4308366609 creator A5005928949 @default.
• W4308366609 creator A5008335692 @default.
• W4308366609 creator A5018042074 @default.
• W4308366609 creator A5028968233 @default.
• W4308366609 creator A5033956313 @default.
• W4308366609 creator A5053948072 @default.
• W4308366609 creator A5056966868 @default.
• W4308366609 date "2022-11-03" @default.
• W4308366609 modified "2023-10-10" @default.
• W4308366609 title "Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination" @default.
• W4308366609 cites W130099911 @default.
• W4308366609 cites W1963914564 @default.
• W4308366609 cites W1979538859 @default.
• W4308366609 cites W2228221433 @default.
• W4308366609 cites W2508911663 @default.
• W4308366609 cites W2734702255 @default.
• W4308366609 cites W2743632419 @default.
• W4308366609 cites W3003415550 @default.
• W4308366609 cites W3020374319 @default.
• W4308366609 cites W3025640515 @default.
• W4308366609 cites W3026323309 @default.
• W4308366609 cites W3042386030 @default.
• W4308366609 cites W3087505215 @default.
• W4308366609 cites W3100840451 @default.
• W4308366609 cites W3120959782 @default.
• W4308366609 cites W3128916397 @default.
• W4308366609 cites W3130799970 @default.
• W4308366609 cites W3141543155 @default.
• W4308366609 cites W3158539237 @default.
• W4308366609 cites W3165477530 @default.
• W4308366609 cites W3181493020 @default.
• W4308366609 cites W3187381326 @default.
• W4308366609 cites W3202680927 @default.
• W4308366609 cites W4285719527 @default.
• W4308366609 cites W4288049703 @default.
• W4308366609 cites W4226238215 @default.
• W4308366609 doi "https://doi.org/10.1001/jamanetworkopen.2022.40403" @default.
• W4308366609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36326760" @default.
• W4308366609 hasPublicationYear "2022" @default.
• W4308366609 type Work @default.
• W4308366609 citedByCount "6" @default.
• W4308366609 countsByYear W43083666092023 @default.
• W4308366609 crossrefType "journal-article" @default.
• W4308366609 hasAuthorship W4308366609A5004646355 @default.
• W4308366609 hasAuthorship W4308366609A5005928949 @default.
• W4308366609 hasAuthorship W4308366609A5008335692 @default.
• W4308366609 hasAuthorship W4308366609A5018042074 @default.
• W4308366609 hasAuthorship W4308366609A5028968233 @default.
• W4308366609 hasAuthorship W4308366609A5033956313 @default.
• W4308366609 hasAuthorship W4308366609A5053948072 @default.
• W4308366609 hasAuthorship W4308366609A5056966868 @default.
• W4308366609 hasBestOaLocation W43083666091 @default.
• W4308366609 hasConcept C121608353 @default.
• W4308366609 hasConcept C126322002 @default.
• W4308366609 hasConcept C126838900 @default.
• W4308366609 hasConcept C188816634 @default.
• W4308366609 hasConcept C20387591 @default.
• W4308366609 hasConcept C2776256026 @default.
• W4308366609 hasConcept C2776463041 @default.
• W4308366609 hasConcept C2777405583 @default.
• W4308366609 hasConcept C2777714996 @default.
• W4308366609 hasConcept C2780221984 @default.
• W4308366609 hasConcept C512399662 @default.
• W4308366609 hasConcept C71924100 @default.
• W4308366609 hasConcept C72563966 @default.
• W4308366609 hasConceptScore W4308366609C121608353 @default.
• W4308366609 hasConceptScore W4308366609C126322002 @default.
• W4308366609 hasConceptScore W4308366609C126838900 @default.
• W4308366609 hasConceptScore W4308366609C188816634 @default.
• W4308366609 hasConceptScore W4308366609C20387591 @default.
• W4308366609 hasConceptScore W4308366609C2776256026 @default.
• W4308366609 hasConceptScore W4308366609C2776463041 @default.
• W4308366609 hasConceptScore W4308366609C2777405583 @default.
• W4308366609 hasConceptScore W4308366609C2777714996 @default.
• W4308366609 hasConceptScore W4308366609C2780221984 @default.
• W4308366609 hasConceptScore W4308366609C512399662 @default.
• W4308366609 hasConceptScore W4308366609C71924100 @default.
• W4308366609 hasConceptScore W4308366609C72563966 @default.
• W4308366609 hasIssue "11" @default.
• W4308366609 hasLocation W43083666091 @default.
• W4308366609 hasLocation W43083666092 @default.
• W4308366609 hasLocation W43083666093 @default.
• W4308366609 hasOpenAccess W4308366609 @default.
• W4308366609 hasPrimaryLocation W43083666091 @default.
• W4308366609 hasRelatedWork W1854257819 @default.
• W4308366609 hasRelatedWork W2005098328 @default.
• W4308366609 hasRelatedWork W2051656428 @default.
• W4308366609 hasRelatedWork W2082588166 @default.
• W4308366609 hasRelatedWork W2789145173 @default.
• W4308366609 hasRelatedWork W2906745831 @default.
• W4308366609 hasRelatedWork W3128474642 @default.
• W4308366609 hasRelatedWork W4281665756 @default.
• W4308366609 hasRelatedWork W4361271779 @default.
• W4308366609 hasRelatedWork W4375946491 @default.
• W4308366609 hasVolume "5" @default.

• next